أعرض في EDS

Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial

التفاصيل البيبلوغرافية
العنوان: Safety and pharmacokinetics of escalating doses of neutralising monoclonal antibody CAP256V2LS administered with and without VRC07-523LS in HIV-negative women in South Africa (CAPRISA 012B): a phase 1, dose-escalation, randomised controlled trial
المؤلفون: Sharana Mahomed, Nigel Garrett, Edmund V Capparelli, Farzana Osman, Nonhlanhla N Mkhize, Ishana Harkoo, Tanuja N Gengiah, Leila E Mansoor, Cheryl Baxter, Derseree Archary, Nonhlanhla Yende-Zuma, Natasha Samsunder, Kevin Carlton, Sandeep Narpala, Adrian B McDermott, Nicole A Doria-Rose, Penny L Moore, Lynn Morris, Quarraisha Abdool Karim, John R Mascola, Salim S Abdool Karim
المصدر: The Lancet HIV. 10:e230-e243
بيانات النشر: Elsevier BV, 2023.
سنة النشر: 2023
مصطلحات موضوعية: Infectious Diseases, Epidemiology, Virology, Immunology
تدمد: 2352-3018
URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::45484837af1a48a8c3fdac285c5230e8
https://doi.org/10.1016/s2352-3018(23)00003-6
حقوق: CLOSED
رقم الأكسشن: edsair.doi...........45484837af1a48a8c3fdac285c5230e8
قاعدة البيانات: OpenAIRE
الوصف
تدمد:23523018